Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive vs Standard BP Control in NSTE-ACS
NCT02135315Completed
- Sponsor
- Université de Monastir
- Start
- Mar 2014
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of isosorbide dinitrate in non-ST elevation acute coronary syndrome (NSTE-ACS) (2 arms), sponsored by Université de Monastir. Primary endpoints: Mortality at 12 months, Major Cardiovascular Events at 12 months and 1 more. Started Mar 2014; status: completed.
02
Drugs
isosorbide dinitrate
03
Conditions
non-ST elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on NCT02135315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135315.